Scientific Advisory Board
JHMRI’s Scientific Advisory Board annually reviews the Institute’s activities, and provides recommendations on organizational, administrative and scientific matters.
Daniel Goldberg, MD, PhD
Professor of Medicine and Molecular Microbiology
Dr. Goldberg is the David L. and Paula M. Kipnis Distinguished Professor of Medicine at Washington University in St. Louis. He served as Director of the Medical Scientist Training Program from 1997 to 2007 and was a Howard Hughes Medical Institute investigator from 1994 to 2014. Goldberg studies the biochemistry of Plasmodium falciparum, focusing on parasite survival in its host erythrocyte.
Diane Griffin, MD, PhD
University Distinguished Service Professor, Department of Molecular Microbiology and Immunology
Dr. Griffin was the founding Director of the Johns Hopkins Malaria Research Institute. She served as the Alfred and Jill Sommer Professor and Chair in the Department of Molecular Microbiology and Immunology from 1994 to 2015. She holds joint appointments in Neurology and Medicine at JHSOM and served as President of the American Society for Virology, the Association of Medical School Microbiology Chairs and the American Society for Microbiology. She currently serves as Vice President of the National Academy of Sciences. Griffin studies the pathogenesis of viral infections.
Thomas Kelly, MD, PhD
Benno C. Schmidt Chair of Cancer Research
Dr. Kelly is is Benno C. Schmidt Chair of Cancer Research, Member of Memorial Sloan Kettering Cancer Center and Professor, Weill Graduate School of Biomedical Sciences, Cornell University. Until March 2013 he served as Director of the Sloan Kettering Institute, where he oversaw a broad research program focused on the causes, diagnosis and treatment of cancer. Prior to joining Sloan Kettering in 2002, Kelly was Professor and Director of the Department of Molecular Biology and Genetics at the Johns Hopkins University School of Medicine and was the founding Director of the Johns Hopkins Institute for Basic Biomedical Sciences. Kelly's work has focused on how the genome is duplicated during the cell cycle, particularly the ways in which replication of DNA is initiated and controlled.
Sanjai Kumar, PhD, MSc
Chief, Laboratory of Emerging Pathogens
Dr. Kumar serves as Chief, Laboratory of Emerging Pathogens at the U.S. Food and Drug Administration. He earned his Master of Science degree in Zoology with a specialization in Parasitology at Lucknow University, India and his PhD in Microbiology at the Central Drug Research Institute in Lucknow, India. His major field of study is the molecular immunology and pathogenesis of malaria and Babesia. In addition, Kumar works on regulation and policy issues related to safety of blood supply against infectious diseases.
Louis Miller, MD
Chief, Malaria Cell Biology Section
Dr. Miller received his B.S. from Haverford College, his M.S. from Columbia University, and his MD from Washington University in St. Louis. He served as a medical resident at Montifiore Hospital, New York, and as an intern and resident at Mount Sinai Hospital. He is a member of the Association of American Physicians, American Society of Clinical Investigation, American Society of Tropical Medicine and Hygiene, Royal Society of Tropical Medicine and Hygiene, National Academy of Sciences, and the National Academy of Medicine. In 2011, he received the Walter Reed Medal for distinguished accomplishment in the field of tropical medicine from the American Society of Tropical Medicine and Hygiene.
Christopher Plowe, MD, MPH, FASTMH
Director, Duke Global Health Institute and Professor of Medicine, Molecular Genetics and Immunology, and Global Health
Dr. Plowe is Professor of Medicine, Molecular Genetics and Immunology, and Global Health at Duke University, where he has directed the Duke Global Health Institute since 2018. He received his MD degree from Cornell University Medical College and his MPH at the Columbia University School of Public Health. He completed residency in internal medicine at St. Luke's Hospital in New York, a malaria research fellowship at NIH and a clinical infectious diseases fellowship at the Johns Hopkins School of Medicine. He is widely recognized for his research on the molecular epidemiology of drug-resistant and "vaccine-resistant" malaria, and presently co-directs an NIH International Center of Excellence for Malaria Research based in Myanmar, China and Bangladesh.
Eric Schoomaker, MD, PhD, Lieutenant General, US Army (retired)
Scholar-in-Residence and Distinguished Professor
Dr. Schoomaker is Professor and Vice Chair for Leadership, Centers and Programs in Military & Emergency Medicine within the School of Medicine of the Uniformed Services University of the Health Sciences. General Schoomaker served as the 42nd Surgeon General of the US Army and Commanding General of the US Army Medical Command. He is an internist and hematologist who has led medical centers such as Walter Reed Army Medical Center; the US Army Medical Research & Materiel Command and Fort Detrick, MD; health regional commands; a community hospital and a multi-functional deployable medical brigade. His interests are in health & healthcare leadership, community well-being and comprehensive integrated pain management.
Alfred Sommer, MD, MHS
Professor of Epidemiology
Dr. Sommer was Dean of the Johns Hopkins Bloomberg School of Public Health from 1990 to 2005. His research interests include outcome assessments, child survival, epidemiology of visual disorders, glaucoma, vitamin A deficiency, blindness prevention strategies, cost-benefit analysis, the growing interface between medicine and public health and clinical guidelines.
Allan Spradling, PhD
Director, Department of Embryology
Dr. Spradling is the Director of the Department of Embryology at the Carnegie Institution of Washington in Baltimore, MD. He holds adjunct appointments in the Department of Biology and the Department of Molecular Biology and Genetics at the Johns Hopkins University and the Johns Hopkins Medical Institutes. Using Drosophila he studies the biology of reproduction. He is interested in stem cells, egg development, and new technology for understanding how genes control tissue development and function. His group investigates the basic biology of tissue stem cells and explores the parallels between germ cell development in Drosophila and mammals.
Kathryn Zoon, PhD
Dr. Zoon is Scientist Emerita at the National Institutes of Health (NIH). Formerly she was Scientific Director, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, NIH. Previously, she served as Deputy Director for Planning and Development at NIAID, NIH Division of Intramural Research and served as the Principal Deputy Director of the Center for Cancer Research at the National Cancer Institute. Before arriving to the NIH, Zoon led the Food and Drug Administration’s Center for Biologics Evaluation and Research. In addition to serving as Associate Editor of the Journal of Interferon Research, Zoon also serves on the Board of Directors of the International Biomedical Research Alliance and Emergent Biosolutions Inc. She is a member of the National Academy of Medicine. She earned her doctorate degree from Johns Hopkins University.